4/A: Apyx Medical Corp CFO Matthew C. Hill Corrects Form 4, Reports Additional Share Purchase
SEC Filing
Matthew C. Hill, CFO of Apyx Medical Corp, amends a previous Form 4 filing to include an additional purchase of 664 shares of common stock.
Summary
- Matthew C. Hill, the Chief Financial Officer of Apyx Medical Corp, filed an amended Form 4 with the SEC.
- The amendment corrects an omission from the original filing on August 13, 2024, regarding a purchase of Apyx Medical Corp common stock.
- The corrected filing includes an additional 664 shares purchased on August 13, 2024, at a weighted average price of $1.13 per share, with prices ranging from $1.12 to $1.13.
- Following the reported transaction, Hill directly owns 8,500 shares of Apyx Medical Corp common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing. The sentiment is neutral as it simply reports a transaction.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This particular filing is an amendment to correct a previous omission, which is not uncommon.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Date of the original transaction and the amended transaction. |
| 08/13/2024 | Date of original filing. |
| 03/03/2025 | Date of signature on the amended form. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.